New hope for early liver cancer: radioembolization under the microscope
NCT ID NCT07278102
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how well a treatment called 90Y radioembolization works for people with early-stage liver cancer. Researchers will track 200 patients in Korea to see how the tumors respond, how long patients live, and any side effects. The goal is to gather real-world data to improve treatment guidelines and expand access to this therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY STAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Hospital
Seoul, Seoul, 03080, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a triple therapy shrink untreatable liver tumors?
- Breath of life: new test could sniff out gut cancers before they spread
- Immune cell therapy takes on untreatable liver cancer
- Could your own immune cells keep liver cancer from coming back?
- New ultrasound technique could reveal hidden blood vessels in liver tumors
- New imaging tracer could spot hidden cancers and fibrosis in one scan